{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:49:43Z","timestamp":1774262983743,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2014.00279","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T23:49:06Z","timestamp":1416008946000},"source":"Crossref","is-referenced-by-count":61,"title":["A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-Up"],"prefix":"10.3389","volume":"4","author":[{"given":"Constantine","family":"Mantz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,11,14]]},"reference":[{"key":"B1"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumors show high sensitivity to fractionation (low \u00ce\u00b1\/\u00ce\u00b2 ratio), similar to late-responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0360-3016(02)03828-2","article-title":"How low is the \u00ce\u00b1\/\u00ce\u00b2 ratio for prostate cancer?","volume":"55","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0360-3016(03)00132-9","article-title":"What hypofractionated protocols should be tested for prostate cancer?","volume":"56","author":"Fowler","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0360-3016(01)01651-0","article-title":"A simple analytic derivation suggests that prostate alpha\/beta ratio is low","volume":"51","author":"King","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0360-3016(01)01607-8","article-title":"Is \u00ce\u00b1\/\u00ce\u00b2 for prostate tumors really low?","volume":"50","author":"Fowler","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0360-3016(00)00591-5","article-title":"Toward optimal external-beam fractionation for prostate cancer","volume":"48","author":"Brenner","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B9","first-page":"747","article-title":"What is the \u00ce\u00b1\/\u00ce\u00b2 ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy","volume":"44","author":"Duschesne","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.semradonc.2008.04.007","article-title":"Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer","volume":"18","author":"Ritter","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","article-title":"The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery","volume":"18","author":"Kirkpatrick","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ijrobp.2007.10.059","article-title":"Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy","volume":"70","author":"Park","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.meddos.2005.03.005","article-title":"A review of prostate motion with considerations for the treatment of prostate cancer","volume":"30","author":"Byrne","year":"2005","journal-title":"Med Dosim"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0360-3016(02)02882-1","article-title":"Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions","volume":"53","author":"Kitamura","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B15","first-page":"14","article-title":"Evaluation of inter- and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed on-board image-guided system","volume":"23","author":"Britton","year":"2005","journal-title":"Radiat Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0360-3016(02)02738-4","article-title":"Intrafraction prostate motion during IMRT for prostate cancer","volume":"53","author":"Huang","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0360-3016(01)02823-1","article-title":"Measurements and clinical consequences of prostate motion during a radiotherapy fraction","volume":"53","author":"Nederveen","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1118\/1.2968333","article-title":"Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT","volume":"35","author":"Hossain","year":"2008","journal-title":"Med Phys"},{"key":"B19","doi-asserted-by":"publisher","first-page":"S355","DOI":"10.1016\/j.ijrobp.2007.07.1446","article-title":"Intra-fraction and inter-fraction prostate motion associated with stereotactic body radiation therapy (SBRT) and image guided radiation therapy (IGRT)","volume":"69","author":"Boike","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ijrobp.2006.10.026","article-title":"Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy","volume":"67","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/00130404-200307000-00009","article-title":"Reduction in acute morbidity using hypofractionated intensity-modulated radiation therapy assisted with a fluoroscopic real-time tumor tracking system for prostate cancer: Preliminary results of a phase I\/II study","volume":"9","author":"Kitamura","year":"2003","journal-title":"Cancer J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ijrobp.2004.09.051","article-title":"Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer","volume":"62","author":"Cheung","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijrobp.2007.10.004","article-title":"Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes","volume":"13","author":"Cahlon","year":"2012","journal-title":"Lancet Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.ijrobp.2005.05.054","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes","volume":"63","author":"Kupelian","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: the Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1470-2045(11)70293-5","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomized controlled trial","volume":"13","author":"Dearnaley","year":"2012","journal-title":"Lancet Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2009.07.1691","article-title":"A prospective phase III randomized trial of hypofractionated versus conventional fractionation in patients with high-risk prostate cancer","volume":"78","author":"Arcangeli","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.2013.51.1972","article-title":"Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer","volume":"31","author":"Pollack","year":"2013","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.ijrobp.2014.01.015","article-title":"Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial","volume":"88","author":"Hoffman","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2490-10-1","article-title":"Stereotactic body radiotherapy for organ-confined prostate cancer","volume":"10","author":"Katz","year":"2010","journal-title":"BMC Urol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.ijrobp.2006.10.050","article-title":"Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in 5 fractions for localized disease: first clinical trial results","volume":"67","author":"Madsen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.clon.2008.08.006","article-title":"Phase I\/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk prostate cancer: early results of pHART3","volume":"20","author":"Tang","year":"2008","journal-title":"Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ijrobp.2010.11.054","article-title":"Long term outcomes from a prostatecive trial of stereotactic body radiotherapy for low-risk prostate cancer","volume":"82","author":"King","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1002\/cncr.26699","article-title":"Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-instituional phase I feasibility trial","volume":"118","author":"McBride","year":"2012","journal-title":"Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1200\/JCO.2010.31.4377","article-title":"Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer","volume":"29","author":"Boike","year":"2011","journal-title":"J Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.radonc.2013.08.030","article-title":"Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials","volume":"109","author":"King","year":"2013","journal-title":"Radiother Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ijrobp.2013.08.019","article-title":"Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials","volume":"87","author":"King","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T19:44:22Z","timestamp":1424288662000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2014.00279\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,14]]},"references-count":37,"URL":"https:\/\/doi.org\/10.3389\/fonc.2014.00279","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,14]]}}}